XRF Scientific Ltd
ASX:XRF

Watchlist Manager
XRF Scientific Ltd Logo
XRF Scientific Ltd
ASX:XRF
Watchlist
Price: 1.82 AUD -0.55%
Market Cap: 255.5m AUD
Have any thoughts about
XRF Scientific Ltd?
Write Note
Section:
 

Relative Value

The Relative Value of one XRF stock under the Base Case scenario is 1.54 AUD. Compared to the current market price of 1.82 AUD, XRF Scientific Ltd is Overvalued by 16%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

XRF Relative Value
Base Case
1.54 AUD
Overvaluation 16%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

4.2
P/S
P/S
Price to Sales
4.2
vs History
1
vs Industry
17
Median 3Y
2.8
Median 5Y
2.5
Industry
1.6
Forward
3.9
More Details
28.3
P/E
P/E
Price to Earnings
28.3
vs History
3
vs Industry
28
Median 3Y
18.7
Median 5Y
15.4
Industry
20.7
Forward
24.7
More Details
31.1
P/OCF
P/OCF
Price to OCF
31.1
vs History
17
vs Industry
20
Median 3Y
23.1
Median 5Y
17.9
Industry
14.8
More Details
46.1
P/FCFE
P/FCFE
Price to FCFE
46.1
vs History
3
vs Industry
17
Median 3Y
26.4
Median 5Y
21.2
Industry
21.3
More Details
4.6
P/B
P/B
Price to Book Value
4.6
vs History
1
vs Industry
14
Median 3Y
3.1
Median 5Y
2.2
Industry
1.8
More Details
4
EV/S
EV/S
Enterprise Value to Sales
4
vs History
1
vs Industry
17
Median 3Y
2.7
Median 5Y
2.3
Industry
1.7
Forward
3.7
More Details
9
EV/GP
EV/GP
Enterprise Value to Gross Profit
9
vs History
6
vs Industry
29
Median 3Y
6.2
Median 5Y
5.2
Industry
6.2
More Details
17.4
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
17.4
vs History
6
vs Industry
29
Median 3Y
12.8
Median 5Y
11.1
Industry
12.4
Forward
14.7
More Details
17.4
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
17.4
vs History
6
vs Industry
36
Median 3Y
12.8
Median 5Y
11.1
Industry
16
Forward
16.3
More Details
29.5
EV/OCF
EV/OCF
Enterprise Value to OCF
29.5
vs History
17
vs Industry
21
Median 3Y
21.7
Median 5Y
17.3
Industry
14.8
More Details
37
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
37
vs History
15
vs Industry
17
Median 3Y
26.9
Median 5Y
19.7
Industry
18.1
More Details
4.6
EV/IC
EV/IC
Enterprise Value to IC
4.6
vs History
1
vs Industry
11
Median 3Y
2.8
Median 5Y
1.9
Industry
1.4
More Details

Multiples Across Competitors

XRF Competitors Multiples
XRF Scientific Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
AU
XRF Scientific Ltd
ASX:XRF
249.3m AUD 4.2 28.3 17.4 17.4
US
Parker-Hannifin Corp
NYSE:PH
83.1B USD 4.2 28.7 18.1 22.2
US
Illinois Tool Works Inc
NYSE:ITW
76.5B USD 4.8 22.1 17.8 19.5
SE
Atlas Copco AB
STO:ATCO A
822.1B SEK 4.7 28.6 18.3 22.5
JP
Mitsubishi Heavy Industries Ltd
TSE:7011
7.5T JPY 1.5 31.6 14.7 21.5
US
Otis Worldwide Corp
NYSE:OTIS
37.3B USD 2.6 22.9 18.9 20.6
US
Ingersoll Rand Inc
NYSE:IR
37B USD 5.2 44.2 21.3 28.4
CH
Schindler Holding AG
SIX:SCHP
26.8B CHF 2.4 44 19.4 26.8
US
Xylem Inc
NYSE:XYL
28.6B USD 3.4 34.4 17.2 25.5
US
Dover Corp
NYSE:DOV
25.9B USD 3.1 16.6 16.6 20.5
US
Fortive Corp
NYSE:FTV
25.8B USD 4.2 29 16.7 24.2
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
AU
XRF Scientific Ltd
ASX:XRF
Average EV/EBITDA: 17.9
17.4
54%
0.3
US
Parker-Hannifin Corp
NYSE:PH
18.1
28%
0.7
US
Illinois Tool Works Inc
NYSE:ITW
17.8
15%
1.2
SE
Atlas Copco AB
STO:ATCO A
18.3
16%
1.1
JP
Mitsubishi Heavy Industries Ltd
TSE:7011
14.7
64%
0.2
US
Otis Worldwide Corp
NYSE:OTIS
18.9
21%
0.9
US
Ingersoll Rand Inc
NYSE:IR
21.3
43%
0.5
CH
Schindler Holding AG
SIX:SCHP
19.4
43%
0.5
US
Xylem Inc
NYSE:XYL
17.2
74%
0.2
US
Dover Corp
NYSE:DOV
16.6
16%
1
US
Fortive Corp
NYSE:FTV
16.7
30%
0.6
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
AU
XRF Scientific Ltd
ASX:XRF
Average EV/EBIT: 22.6
17.4
41%
0.4
US
Parker-Hannifin Corp
NYSE:PH
22.2
36%
0.6
US
Illinois Tool Works Inc
NYSE:ITW
19.5
15%
1.3
SE
Atlas Copco AB
STO:ATCO A
22.5
18%
1.3
JP
Mitsubishi Heavy Industries Ltd
TSE:7011
21.5
N/A N/A
US
Otis Worldwide Corp
NYSE:OTIS
20.6
21%
1
US
Ingersoll Rand Inc
NYSE:IR
28.4
72%
0.4
CH
Schindler Holding AG
SIX:SCHP
26.8
62%
0.4
US
Xylem Inc
NYSE:XYL
25.5
108%
0.2
US
Dover Corp
NYSE:DOV
20.5
22%
0.9
US
Fortive Corp
NYSE:FTV
24.2
46%
0.5

See Also

Summary
XRF intrinsic value, competitors valuation, and company profile.
DCF Valuation
XRF stock valuation using Discount Cash Flow valuation method.
Relative Valuation
XRF stock valuation using valuation multiples.
Wall Street Estimates
XRF price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
XRF stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 210,500+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.